Case 2
A 20-year-old African American woman with NDCM, HFrEF of 20%, and
diabetes mellitus presented in acute decompensated heart failure
thirteen months after ICD placement (EF 5%, NYHA Class IV, Stage D).
Impella 5.5 (Abiomed, Danvers, MA) was implanted. She was listed UNOS
status 1. Ten weeks later, she underwent transplant after she/donor
tested SARS-CoV-2 negative. Standard immunosuppression was implemented
after induction with rabbit anti-thymocyte globulin and mycophenolate
mofetil. On postoperative day ten, she was discharged home following an
uncomplicated hospital course. She continues to progress well. Eight
months postoperatively, she has consistently tested negative for
SARS-CoV-2, with no evidence of rejection.